103 results
424B5
RVMD
Revolution Medicines, Inc.
7 Aug 24
Prospectus supplement for primary offering
5:07pm
is owned by the users of its regulated subsidiaries. Access to the DTC system is also available to others, which we sometimes refer to as indirect
8-K
EX-99.1
RVMD
Revolution Medicines, Inc.
7 Aug 24
Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress
4:05pm
, or access the archived webcast, please visit: https://ir.revmed.com/events-and-presentations. Following the live webcast, a replay will be available
8-K
EX-99.1
gv0 rishny082p
8 May 24
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress
4:05pm
DEFA14A
pnu4tqx jc
25 Apr 24
Additional proxy soliciting materials
4:35pm
S-3ASR
151nyl 6o
4 Mar 24
Automatic shelf registration
5:23pm
8-K
EX-99.1
qm0lf y56mseocr
26 Feb 24
Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress
4:04pm
8-K
EX-99.1
okh81lhzww5uhb2 bz
6 Nov 23
Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate Progress
4:05pm
425
wua 6ybsvc7ivo
23 Oct 23
Business combination disclosure
6:13am
DEFM14A
isfrf1268vkgkqz
29 Sep 23
Proxy related to merger
4:19pm
424B3
p1iq37a
29 Sep 23
Prospectus supplement
4:17pm
S-4/A
EX-99.3
olwr48mbh fk
27 Sep 23
Registration of securities issued in business combination transactions (amended)
5:25pm